Kurt Schrader sold Invesco Plc (NYSE: IVZ)
Kurt Schrader (D-OR), a U.S. Representative, has disclosed 1 trade in Invesco Plc (IVZ) since 2017, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Kurt Schrader sold $1,001 - $15,000 of Invesco Plc (NYSE: IVZ) on January 14, 2017. Since that trade, IVZ is up +39.17% against the S&P 500 up +272.12%, an outperformance of -232.95%.
Data updated
Kurt Schrader's IVZ trades vs the price
IVZ is up +39.17% since Kurt Schrader sold on January 14, 2017, versus +272.12% for the S&P 500.
Performance since this trade
All Kurt Schrader IVZ trades
Kurt Schrader & IVZ trading FAQ
Is it legal for Kurt Schrader to trade Invesco Plc (IVZ) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Invesco Plc (IVZ), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Kurt Schrader sell IVZ?
Kurt Schrader disclosed a sale of $1,001 - $15,000 of Invesco Plc (IVZ) on January 14, 2017, according to public STOCK Act filings.
How has IVZ performed since Kurt Schrader's trade?
Since Kurt Schrader sold IVZ on January 14, 2017, the stock is up +39.17%, versus +272.12% for the S&P 500 over the same period, an outperformance of -232.95%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional IVZ trades?
Quantellect tracks every disclosed congressional trade in Invesco Plc (IVZ) on the Invesco Plc congressional trading page, which aggregates filings across all members of Congress.
Kurt Schrader's IVZ tradesAll congressional filings for Invesco PlcKurt Schrader's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.